Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors

Clinical Chemistry

Volumn 48, Issue 10, 2002, Pages 1720-1730

  Adnan El Masri, M ^a   Clark, Barbara J ^a   Qazzaz, Hassan M ^a   Valdes Jr , Roland ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BUCLADESINE; CARDENOLIDE DERIVATIVE; DIGITALIS LIKE FACTOR; DIHYDROOUABAIN; DIHYDROOUABAIN LIKE FACTOR; UNCLASSIFIED DRUG;

ADRENAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL STIMULATION; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

MAMMALIA; STROPHANTHUS GRATUS;

EID: 0036792397     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.10.1720     Document Type: Article

References (40)

1. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 1991;88:6259-63.
2. De Angelis C, Riscazzi M, Salvini R, Piccoli A, Ferri C, Santucci A. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography. Clin Chem 1997;43:1416-20.
3. Hinson JP, Harwood S, Dawnay AB. Release of ouabain-like compound (OLC) from the intact perfused rat adrenal gland. Endocr Res 1998;24:721-4.
4. Qazzaz HM, El-Masri MA, Valdes R Jr. Secretion of a lactonehydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells. Endocrinology 2000;141:3200-9.
5. Ludens JH, Clark MA, Robinson FG, DuCharme DW. Rat adrenal cortex is a source of a circulating ouabainlike compound. Hypertension 1992;19:721-4.
6. Beck M, Szalay KS, Nagy GM, Toth M, de Chate R. Production of ouabain by rat adrenocortical cells. Endocr Res 1996;22:845-9.
7. Li S, Eim C, Kirch U, Lang RE, Schoner W. Bovine adrenals and hypothalamus are a major source of proscillaridin A- and ouabain-immunoreactivities. Life Sci 1998;62:1023-33.
8. Tymiak A, Norman J, Bolgar M, DiDonato G, Lee H, Parker W, et al. Physiochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A 1993;90:8189-93.
9. Shah JR, Laredo J, Hamilton BP, Hamlyn JM. Different signaling pathways mediate stimulated secretion of endogenous ouabain and aldosterone from bovine adrenocortical cells. Hypertension 1998;31:463-8.
10. Doris PA, Hayward-Lester A, Bourne D, Stocco DM. Ouabain production by cultured adrenal cells. Endocrinology 1996;137:533-9.
11. Laredo J, Hamilton BP, Hamlyn JM. Ouabain is secreted bovine adrenocortical cells. Endocrinology 1994;135:794-7.
12. Doris PA. Regulation of Na,K-ATPase by endogenous ouabain-like materials. Exp Biol Med 1994;205:202-12.
13. Doris PA. Endogenous inhibitors of the Na,K pump. Miner Electrolyte Metab 1996;22:303-10.
14. Hollenberg NK, Graves SW. Endogenous sodium pump inhibition: current status therapeutic opportunities. Prog Drug Res 1996;46:9-42.
15. Rose AM, Valdes R Jr. Understanding the sodium pump and its relevance to disease. Clin Chem 1994;40:1674-85.
16. Li R, El-Mallakh RS, Harrison L, Changaris DG, Levy RS. Lithium prevents ouabain-induced behavioral changes. Mol Chem Neuropathol 1997;31:65-72.
17. Ferrandi M, Manunta P. Ouabain-like factor: is this the natriuretic hormone? Curr Opin Nephrol Hypertens 2000;9:165-71.
18. Ludnes JH, Clark MA, DuCharme DW, Harris DW, Lutzke BS, Mandel F, et al. Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension 1991;17:923-9.
19. Goto A, Yamada K. Ouabain-like factor. Curr Opin Nephrol Hypertens 1998;7:189-96.
20. Bagrov AY, Fedorova OV, Austin-Lane JL, Dmitrieva RI, Anderson DE. Endogenous marinobufagenin-like immunoreactive factor and Na,K-ATPase inhibition during voluntary hypoventilation. Hypertension 1995;26:781-8.
21. Dmitrieva RI, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM, Doris PA. Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage. Hypertension 2000;36:442-8.
22. Schoner W, Kirch U, Sich B, Antonolovich R. Purification and some properties of an inhibitor of the sodium pump from bovine adrenals cross-reacting with proscillaridin A antibodies. Biol Chem Hoppe Seyler 1993;374:SP-181.
23. Mathews WR, DuCharme DW, Hamlyn JM, Harris DW, Mandel F, Clark MA, et at. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension 1991;17:930-5.
24. El-Masri MA, Qazzaz HM, Clark BJ, Valdes R Jr. Production of ouabain-like factor (OLF) and it's chemically reduced form dihydroouabain-like factor (dihydro-OLF) by human adrenal cells [Abstract]. FASEB J 2000;14:A1536.
25. Qazzaz MA, El-Masri MA, Stolowich NJ, Valdes R Jr. Two biologically active isomers of dihydroouabain isolated from a commercial preparation. Biochim Biophys Acta 1999;1472:486-97.
26. +)-membrane-ATPase and positive inotropic activity of cardenolides in isolated papillary muscles of guinea pig. Naunyn Schmiedebergs Arch Pharmacol 1978;304:37-44.
27. Feng J, Lingrel JB. Analysis of amino acid residues in the H5-H6 transmembrane and extracellular domains of the Na,K-ATPase α subunit identifies threonine 797 as a determinant of ouabain sensitivity. Biochemistry 1994;33:4218-24.
28. Butler VP Jr, Tse-Eng D, Lindenbaum J, Kalman SM, Preibisz JJ, Rund DG, et al. The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite. J Pharmacol Exp Ther 1982;221:123-31.
29. Hamlyn JM, Lu Z, Manunta P, Ludens JH, Kimura K, Shah JR, et al. Observation on the nature, biosynthesis, secretion, and significance of endogenous ouabain. Clin Exp Hypertens 1998;20:523-33.
30. Fernandez-Botran F, Vetvicka V, eds. Methods in cellular immunology. Boca Raton, FL: CRC Press, 1995:203-4.
31. + in H295R human adrenocortical cells. Mol Cell Endocrinol 1995;115:215-9.
32. Resko JA, Norman GD, Niswender GD, Spies HG. The relationship between progestins and gonadotropins during the late luteal phase of the menstrual cycle in rhesus monkeys. Endocrinology 1974;94:128-35.
33. +-ATPase inhibitors. Clin Biochem 1992;25:15-9.
34. Vakkuri OS, Arnason SS, Pouta A, Vuolteenaho O. Radioimmunoassay of plasma ouabain in healthy and pregnant individuals. J Endocrinol 2000;165:669-77.
35. 14C-labelled mammalian ouabain-like factors (OLF) using mouse adrenal Y-1. J Clin Ligand Assay 2002;in press.
36. Clark BJ, Combs R. Angiotensin II and cyclic adenosine 3′,5′-monophosphate induce human steroidogenic acute regulatory protein transcription through a common steroidogenic factor-1 element. Endocrinology 1999;140:4390-8.
37. Shah JR, Laredo J, Hamilton BP, Hamlyn JM. Effects of angiotensin II on sodium potassium pumps, endogenous ouabain and aldosterone in bovine zona glomerulosa cells. Hypertension 1999;33:373-7.
38. Pena C, Arnaiz de Lores GR. Differential properties between an endogenous brain Na,K-ATPase inhibitor and ouabain. Neurochem Res 1997;22:379-83.
39. Li M, Wong KS, Martin A, Withworth A. Adrenocorticotrophin-induced hypertension in rats. Am J Hypertens 1994;7:59-68.
40. Perrin A, Brasmes B, Chambaz, EM, Defaye G. Bovine adrenocortical cells in culture synthesize an ouabain-like compound. Mol Cell Endocrinol 1997;126:7-15.